Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML

Clinical trial NCT03504410 · TERMINATED

Trial details

NCT number: NCT03504410
Sponsor: Cornerstone Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory Acute Myeloid Leukemia

Start date: 2018-11-12
Primary completion: 2021-10-25
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.